Other platelet-activating anti-PF4 disorders

This code identifies acquired disorders characterized by the immune system producing antibodies that activate platelets, specifically targeting platelet factor 4 (PF4), but which do not meet the criteria for heparin-induced thrombocytopenia (HIT). These conditions often involve thrombotic complications or thrombocytopenia due to the immune-mediated platelet activation.

Apply this code for patients diagnosed with non-heparin-induced, immune-mediated platelet-activating anti-PF4 disorders. This includes conditions like spontaneous HIT-like syndrome (S-HITS) or vaccine-induced immune thrombotic thrombocytopenia (VITT) when the specific anti-PF4 antibody activation is documented. Documentation should clearly state the presence of anti-PF4 antibodies and evidence of platelet activation or associated thrombotic events, excluding heparin as the causative agent.

• Differentiate carefully from true heparin-induced thrombocytopenia (HIT); this code is for other anti-PF4 disorders.
• Ensure documentation specifies "anti-PF4 antibodies" and "platelet activation" in the absence of heparin exposure.
• Consider sequencing this code as a primary diagnosis when it is the reason for the encounter, especially in cases of VITT or S-HITS.